Health Care/Hospital

DiNovA's Israel Incubator officially opens its office in Caesarea

CAESAREA, Israel, June 4, 2021 /PRNewswire/ -- China headquartered DiNovA Medtech officially takes up residence in Caesarea Industry and Business Park for itsIsrael incubator, which continues to help augment the company's global footprint. DiNovA Medtech is not new to Israel. Its leadership team...

2021-06-04 14:00 1656

Elekta Nomination Committee's proposed Board of Directors for the 2021 Annual General Meeting

STOCKHOLM, June 4, 2021 /PRNewswire/ -- The Nomination Committee of Elekta (EKTA-B.ST) proposes that the 2021 Annual General Meeting re-elect Board members Laurent Leksell, who is also proposed to be re-elected as Chairman of the Board, Caroline Leksell Cooke, Johan Malmquist, Wolfgang Reim, Jan Se...

2021-06-04 13:56 1850

Prixa Closes US$3 million in Additional Funding to Enhance Accessibility and Digital Transformation of Indonesian Healthcare Services

* Funding led by MDI Ventures (MDI) and the Trans-Pacific Technology Fund (TPTF) with participation from existing investors including Siloam Hospitals Group. * This strategic investment will allow Prixa to expand its digital healthcare platform and user base. * Prixa is a leading health-tec...

2021-06-04 11:13 2384

Antengene Announces Publication of Abstract on XPO1 Inhibitor Selinexor in Relapsed or Refractory Multiple Myeloma at ASCO 2021 and EHA 2021

SHANGHAI and HONG KONG, June 4, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...

2021-06-04 08:00 2794

Vela Diagnostics Announces Collaboration with the National Cancer Centre of Singapore to Refine Novel Cancer Therapy

SINGAPORE, June 4, 2021 /PRNewswire/ -- Vela Diagnostics announced a collaboration with the National Cancer Centre ofSingapore (NCCS) to develop a molecular diagnostic assay to predict individual patients' responses to a cancer therapy called Epidermal Growth Factor Receptor (EGFR) tyrosine kinas...

2021-06-04 08:00 1817

WCPGHAN 2021: Fish oil taken during pregnancy boosts problem-solving and concentration in children, new data reveals

GENEVA, June 4, 2021 /PRNewswire/ -- Children born to mothers who took fish oil in their pregnancies have been shown to have faster problem-solving skills and better attention focus at age 10, according to findings from an EU funded study presented today at the 6th World Congress of Paediatric Ga...

2021-06-04 07:01 2150

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial

1. VISEN Pharmaceuticals has obtained the investigational new drug (IND) approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for the phase III China clinical trial (PaTHway China Trial) of TransCon PTH Solution for Injection (TransCon™ parathy...

2021-06-04 02:00 1933

RWDC Industries Appoints New Chief Financial Officer

Thomas Aebischer brings 18 years of public and private company CFO experience and proven leadership track record to RWDC ATHENS, Georgia and SINGAPORE, June 3, 2021 /PRNewswire/ -- RWDC Industries, a biotechnology company on a mission to replace single-use plastics through innovative and cost-ef...

2021-06-03 22:00 2076

Innovent and Lilly Jointly Announce the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with Gemcitabine and Platinum Chemotherapy as First-Line Therapy for People with Squamous Non-Small Cell Lung Cancer

SAN FRANCISCO and SUZHOU, China, June 3, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disease...

2021-06-03 17:09 4437

Peking University Biologics entering into Strategic Cooperation Agreement with Norwich Investment Limited

HONG KONG, June 3, 2021 /PRNewswire/ -- Peking University Biologics (hereinafter known as "PKU BIO") and Norwich Investment Limited (hereinafter known as "Norwich") announced today that both parties have entered into a Strategic Cooperation Agreement ("Agreement") to promote the business develop...

2021-06-03 16:29 2688

Innophys Releases "MUSCLE SUIT Every" in Italy

TOKYO, June 3, 2021 /PRNewswire/ -- - Accelerating Sales in EU Member Countries - Innophys Co., Ltd. (hereinafter "Innophys") released wearable work-assisting robotic suit "MUSCLE SUIT Every" inItaly on June 3 as part of its efforts to promote the sale of the product overseas, particularly in th...

2021-06-03 14:00 1309

Grifols to provide Korean Red Cross with Procleix Panther for blood screening, extending donor testing leadership in Asia

- The 28 systems to be deployed across KRC's three laboratory sites will test about 94% of the country's blood donations - They will run the Procleix Ultrio Elite Assay, an advanced nucleic acid test (NAT) ensuring donation safety by detecting the potential presence of the most important infecti...

2021-06-03 11:00 2752

Clinical Trial Results of the BCMA CAR-T Co-developed by Innovent and IASO Biotherapeutics Commented in American Society of Hematology's Medical Journal "Blood"

SAN FRANCISCO, U.S. and SUZHOU, China, June 3, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major ...

2021-06-03 08:00 4464

First Patient Dosed in QBiotics & MSD Clinical Trial Collaboration for Unresectable Melanoma

* First patient dosed with QBiotics' lead oncology molecule tigilanol tiglate in combination with KEYTRUDA® (pembrolizumab) in a clinical trial collaboration with MSD (tradename of Merck & Co., Inc.,Kenilworth, NJ, USA) * The Phase Ib/IIa study will test the safety, optimal dose and tumour re...

2021-06-03 06:00 1830

IDEXX Acquires ezyVet

Global leader in veterinary diagnostics and software enhances its practice management portfolio with acquisition of leading cloud-based solution WESTBROOK, Maine, June 3, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, announc...

2021-06-03 04:53 12627

Payment Integrity Solutions Enable Healthcare Plans to Optimize Processes and Maximize Returns

External prepayment processing experts decrease incorrect payments in high-cost inpatient and outpatient facility claims, finds Frost & Sullivan SANTA CLARA, Calif., June 3, 2021 /PRNewswire/ -- Payment integrity solutions are evolving in terms of technology, strategy, and services for higher cla...

2021-06-03 03:32 1318

Nanoform raises its mid-term business targets for 2025

HELSINKI, June 2, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced its raised mid-term business targets for 2025. The new targets are as follows:            * To nanoform annually at least 70 new active pharmaceutical ...

2021-06-02 21:42 1424

Mindray Launches Resona I9 Ultrasound System, Revolutionizing General Imaging

SHENZHEN, China, June 2, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has announced the release of its latest general imaging diagnostic ultrasound system,Resona I9 , to it...

2021-06-02 19:04 6259

Menopause to Become the Next Game-changer in the Global Femtech Solutions Industry by 2025

SANTA CLARA, Calif., June 2, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis on theglobal femtech solutions industry finds that the COVID-19 pandemic has led to a dramatic rise in women's physical and mental health issues. While digital health solutions, now under the broader term of virt...

2021-06-02 18:03 1227

Betagenon AB announces investment and collaboration with Hong Kong-based MCG Technology Group Ltd

STOCKHOLM, June 2, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based biotech company focused on development of AMPK activator compounds, and MCG Technology Group Ltd, aHong Kong-based biotech investment group, today announced that MCG Technology Group will invest in and collaborate with Betagenon...

2021-06-02 16:23 1278
1 ... 330331332333334335336 ... 554